In addition, although present second-generation photosensitizers conjugated to Lgr5 antibodies bind to both cancer stem cells and normal stem cells, NIR illumination using depth-based treatment localization as demonstrated here would enable the selective targeting of cancer stem cells up to 500 μm from the luminal surface. Here, LGR5 is linked to cancer.